The international law firm Milbank LLP advised the existing shareholders of PharmaSGP Holding SE on the first successful IPO in 2020 in the Prime Standard segment of the Frankfurt Stock Exchange. PharmaSGP Holding SE is a consumer health company based in Gräfelfing near Munich that offers a broad portfolio of leading chemical-free, non-prescription pharmaceuticals sold over the counter (“OTC”) and other healthcare products.
In the course of the IPO, 4.025 million shares of PharmaSGP Holding SE were placed from the holdings of the existing shareholders, of which 0.525 million shares were placed as part of an over-allotment (“Greenshoe”), at €31.50 per share. Stock exchange trading commenced on 19 June 2020. The placement resulted in a free float of approximately 33.5% after the IPO.
Milbank comprehensively advised the existing shareholders on corporate, capital markets and tax law aspects of the IPO.
Advisor to Existing Shareholders: Milbank LLP
Christoph Rothenfusser, Norbert Rieger (both Corporate/M&A, Munich), Matthias Schell (Tax, Munich), Sebastian Reiner-Pechtl, Hauke Lorenzen, Malte Krohn (all Corporate/M&A, Munich) and Arne Hammerich (Tax, Munich).
Originally published by Milbank, July 2020
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.